These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 23069661)

  • 1. Lactotransferrin acts as a tumor suppressor in nasopharyngeal carcinoma by repressing AKT through multiple mechanisms.
    Deng M; Zhang W; Tang H; Ye Q; Liao Q; Zhou Y; Wu M; Xiong W; Zheng Y; Guo X; Qin Z; He W; Zhou M; Xiang J; Li X; Ma J; Li G
    Oncogene; 2013 Sep; 32(36):4273-83. PubMed ID: 23069661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-214 promotes tumorigenesis by targeting lactotransferrin in nasopharyngeal carcinoma.
    Deng M; Ye Q; Qin Z; Zheng Y; He W; Tang H; Zhou Y; Xiong W; Zhou M; Li X; Yan Q; Ma J; Li G
    Tumour Biol; 2013 Jun; 34(3):1793-800. PubMed ID: 23479198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactoferrin mediates epithelial-mesenchymal transformation by regulating the PI3K/AKT/mTOR pathway to inhibit nasopharyngeal carcinoma metastasis.
    Xu M; Fan Y; Zou G; Yang Q; Xu F
    Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):130-135. PubMed ID: 38650146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactotransferrin: a candidate tumor suppressor-Deficient expression in human nasopharyngeal carcinoma and inhibition of NPC cell proliferation by modulating the mitogen-activated protein kinase pathway.
    Zhou Y; Zeng Z; Zhang W; Xiong W; Wu M; Tan Y; Yi W; Xiao L; Li X; Huang C; Cao L; Tang K; Li X; Shen S; Li G
    Int J Cancer; 2008 Nov; 123(9):2065-72. PubMed ID: 18697201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA‑122 acts as tumor suppressor by targeting TRIM29 and blocking the activity of PI3K/AKT signaling in nasopharyngeal carcinoma in vitro.
    Yang Y; Li Q; Guo L
    Mol Med Rep; 2018 Jun; 17(6):8244-8252. PubMed ID: 29693120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Underlying mechanisms for LTF inactivation and its functional analysis in nasopharyngeal carcinoma cell lines.
    Zhang H; Feng X; Liu W; Jiang X; Shan W; Huang C; Yi H; Zhu B; Zhou W; Wang L; Liu C; Zhang L; Jia W; Huang W; Li G; Shi J; Wanggou S; Yao K; Ren C
    J Cell Biochem; 2011 Jul; 112(7):1832-43. PubMed ID: 21400573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactotransferrin could be a novel independent molecular prognosticator of nasopharyngeal carcinoma.
    Zhang W; Fan S; Zou G; Shi L; Zeng Z; Ma J; Zhou Y; Li X; Zhang X; Li X; Tan M; Xiong W; Li G
    Tumour Biol; 2015 Feb; 36(2):675-83. PubMed ID: 25286756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 14-3-3sigma, a p53 regulator, suppresses tumor growth of nasopharyngeal carcinoma.
    Yang H; Zhao R; Lee MH
    Mol Cancer Ther; 2006 Feb; 5(2):253-60. PubMed ID: 16505098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway.
    Hu W; Xiao L; Cao C; Hua S; Wu D
    Oncotarget; 2016 Mar; 7(12):15161-72. PubMed ID: 26943030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DOC-2/DAB2 interactive protein regulates proliferation and mobility of nasopharyngeal carcinoma cells by targeting PI3K/Akt pathway.
    Wang B; Gu Q; Li J
    Oncol Rep; 2017 Jul; 38(1):317-324. PubMed ID: 28586035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The important role of the receptor for activated C kinase 1 (RACK1) in nasopharyngeal carcinoma progression.
    Peng H; Gong PG; Li JB; Cai LM; Yang L; Liu YY; Yao KT; Li X
    J Transl Med; 2016 May; 14(1):131. PubMed ID: 27170279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-Src activation promotes nasopharyngeal carcinoma metastasis by inducing the epithelial-mesenchymal transition via PI3K/Akt signaling pathway: a new and promising target for NPC.
    Ke L; Xiang Y; Guo X; Lu J; Xia W; Yu Y; Peng Y; Wang L; Wang G; Ye Y; Yang J; Liang H; Kang T; Lv X
    Oncotarget; 2016 May; 7(19):28340-55. PubMed ID: 27078847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and epigenetic alterations of LTF at 3p21.3 in nasopharyngeal carcinoma.
    Yi HM; Li H; Peng D; Zhang HJ; Wang L; Zhao M; Yao KT; Ren CP
    Oncol Res; 2006; 16(6):261-72. PubMed ID: 17476971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-141 is involved in BRD7-mediated cell proliferation and tumor formation through suppression of the PTEN/AKT pathway in nasopharyngeal carcinoma.
    Liu Y; Zhao R; Wang H; Luo Y; Wang X; Niu W; Zhou Y; Wen Q; Fan S; Li X; Xiong W; Ma J; Li X; Tan M; Li G; Zhou M
    Cell Death Dis; 2016 Mar; 7(3):e2156. PubMed ID: 27010857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-16 targets fibroblast growth factor 2 to inhibit NPC cell proliferation and invasion via PI3K/AKT and MAPK signaling pathways.
    He Q; Ren X; Chen J; Li Y; Tang X; Wen X; Yang X; Zhang J; Wang Y; Ma J; Liu N
    Oncotarget; 2016 Jan; 7(3):3047-58. PubMed ID: 26655091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IKBB tumor suppressive role in nasopharyngeal carcinoma via NF-κB-mediated signalling.
    Phoon YP; Cheung AK; Cheung FM; Chan KF; Wong S; Wong BW; Tung SY; Yau CC; Ng WT; Lung ML
    Int J Cancer; 2016 Jan; 138(1):160-70. PubMed ID: 26227166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of CACNA2D3 as a putative tumor suppressor gene in the development and progression of nasopharyngeal carcinoma.
    Wong AM; Kong KL; Chen L; Liu M; Wong AM; Zhu C; Tsang JW; Guan XY
    Int J Cancer; 2013 Nov; 133(10):2284-95. PubMed ID: 23649311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down regulation of lactotransferrin enhanced radio-sensitivity of nasopharyngeal carcinoma.
    Qi YF; Yang Y; Zhang Y; Liu S; Luo B; Liu W
    Comput Biol Chem; 2021 Feb; 90():107426. PubMed ID: 33352501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN.
    Zhang LY; Ho-Fun Lee V; Wong AM; Kwong DL; Zhu YH; Dong SS; Kong KL; Chen J; Tsao SW; Guan XY; Fu L
    Carcinogenesis; 2013 Feb; 34(2):454-63. PubMed ID: 23125220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LASP1 promotes nasopharyngeal carcinoma progression through negatively regulation of the tumor suppressor PTEN.
    Gao Q; Tang L; Wu L; Li K; Wang H; Li W; Wu J; Li M; Wang S; Zhao L
    Cell Death Dis; 2018 Mar; 9(3):393. PubMed ID: 29531214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.